Pulmonology · Acid-Base Disturbances
The facts most likely to be tested
Respiratory acidosis is defined by a pH < 7.35 and a PaCO2 > 45 mmHg resulting from alveolar hypoventilation.
Acute respiratory acidosis causes a minimal rise in serum bicarbonate (typically 1 mEq/L for every 10 mmHg rise in PaCO2) due to limited renal compensation.
Chronic respiratory acidosis is characterized by significant renal compensation via increased bicarbonate reabsorption, resulting in a rise of 3.5–4 mEq/L for every 10 mmHg rise in PaCO2.
The most common cause of acute respiratory acidosis is central nervous system depression from opioid overdose or sedative-hypnotic use.
Obstructive lung diseases like COPD are the classic etiology of chronic respiratory acidosis due to chronic ventilation-perfusion (V/Q) mismatch.
Neuromuscular disorders such as Guillain-Barré syndrome or myasthenia gravis cause respiratory acidosis by inducing diaphragmatic weakness and respiratory failure.
The primary treatment for respiratory acidosis is addressing the underlying cause and improving alveolar ventilation via non-invasive positive pressure ventilation (NIPPV) or mechanical ventilation.
Vignette unlocked
A 68-year-old male with a 40-pack-year smoking history presents to the emergency department with increased shortness of breath and lethargy. Physical examination reveals pursed-lip breathing, bilateral wheezing, and peripheral edema. Arterial blood gas analysis shows a pH of 7.28, PaCO2 of 62 mmHg, and a bicarbonate of 32 mEq/L. The patient is currently alert but struggling to maintain his respiratory effort.
What is the most appropriate initial management for this patient's respiratory failure?
Non-invasive positive pressure ventilation (NIPPV)
The patient has chronic respiratory acidosis with acute decompensation; NIPPV is the first-line treatment to reduce the work of breathing and improve CO2 clearance in COPD exacerbations.
Full handout
High yield triage
Etiology / Epidemiology
Caused by alveolar hypoventilation leading to CO2 retention. Common in COPD, neuromuscular disease, and opioid overdose.
Clinical Manifestations
Presents with somnolence, confusion, and asterixis. Severe cases show CO2 narcosis and papilledema.
Diagnosis
Diagnosis via Arterial Blood Gas (ABG). Defined by pH < 7.35 and PaCO2 > 45 mmHg.
Treatment
Primary goal is improving ventilation. Use NIPPV or mechanical ventilation; avoid over-correction.
Prognosis
Risk of cardiac arrhythmias and respiratory failure. Monitor bicarbonate levels for chronic compensation.
Full handout
Epidemiology & Etiology
Respiratory acidosis results from failure of the respiratory system to eliminate CO2. Major etiologies include obstructive lung disease, CNS depression, and chest wall abnormalities like kyphoscoliosis. It is frequently seen in patients with acute exacerbation of COPD.
Pertinent Anatomy
The medulla oblongata serves as the primary respiratory center, sensitive to changes in pH and PaCO2. The diaphragm and intercostal muscles are the primary effectors of ventilation. Impairment of the phrenic nerve or neuromuscular junction prevents adequate tidal volume.
Pathophysiology
Hypoventilation causes an increase in PaCO2, shifting the equilibrium toward increased H+ and HCO3-. In acute cases, the body has not yet compensated, leading to a rapid drop in pH. In chronic cases, the kidneys retain HCO3- to buffer the acid, resulting in a near-normal pH despite elevated PaCO2.
Clinical Manifestations
Patients often present with headache, anxiety, and asterixis (flapping tremor). Red flags include seizures, coma, and papilledema secondary to cerebral vasodilation. Chronic patients may be asymptomatic but exhibit polycythemia due to chronic hypoxemia.
Diagnosis
The Arterial Blood Gas (ABG) is the gold standard for diagnosis. Findings include pH < 7.35 and PaCO2 > 45 mmHg. Calculate the bicarbonate compensation: for every 10 mmHg rise in PaCO2, HCO3- should rise by 1 mEq/L (acute) or 3.5 mEq/L (chronic).
Treatment
The priority is airway management and assisted ventilation. NIPPV (BiPAP) is the first-line treatment for COPD exacerbations. Avoid rapid normalization of PaCO2 to prevent post-hypercapnic metabolic alkalosis and seizures. Use bronchodilators or naloxone if the underlying cause is bronchospasm or opioid toxicity.
Prognosis
Complications include pulmonary hypertension and cor pulmonale. Patients require serial ABG monitoring to ensure adequate ventilation without inducing alkalemia. Failure to correct leads to respiratory arrest.
Differential Diagnosis
Metabolic Acidosis: low HCO3- rather than high PaCO2
Respiratory Alkalosis: pH > 7.45 and PaCO2 < 35 mmHg
Mixed Acid-Base Disorder: presence of both metabolic and respiratory components
COPD Exacerbation: history of smoking and obstructive spirometry
Opioid Overdose: pinpoint pupils and decreased respiratory rate